Drug-labels.com

Apo-Memantine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
10 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Apo-Memantine

ABOUT THIS MEDICATION

What the medication is used for:

APO-MEMANTINE has been prescribed to you, by a doctor to relieve symptoms of Alzheimer’s disease.

What it does:

The brain contains N-methyl-D-aspartate (NMDA) receptors that are involved in transmitting nerve signals and may be important for learning and memory. Abnormal transmission of nerve signals through NMDA-receptors in the brain may affect memory and other mental functions and contribute to symptoms of Alzheimer’s disease. APO-MEMANTINE belongs to a group of medicines called NMDA-receptor antagonists. The action of APO-MEMANTINE on NMDA-receptors may help normalize the transmission of nerve signals, which may help slow the decline in some of the symptoms of Alzheimer disease.

When it should not be used:

You should not be taking APO-MEMANTINE

  • if you are pregnant, unless in the opinion of the

    doctor, the expected benefit to the patient markedly outweighs the possible hazards to the foetus.

  • You should not be taking APO-MEMANTINE

    if you are breast-feeding.

    • Do not take APO-MEMANTINE if you are allergic to it, or to any of the other ingredients listed in this leaflet (see ‘What the non-medicinal ingredients are’).
    • Stop taking APO-MEMANTINE if you experience an allergic reaction or any severe side effect.

What the medicinal ingredient is:

Memantine hydrochloride

What the nonmedicinal ingredients are: Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hydroxypropylcellulose,

hydroxypropylmethylcellulose, polyethylene glycol and titanium dioxide.

What dosage forms it comes in:

White 10 mg tablets in blister packs and bottles.

WARNINGS AND PRECAUTIONS

BEFORE you use APO-MEMANTINE talk to your doctor or pharmacist if:

  • You have/had a medical condition, including heart problems, uncontrolled hypertension (high blood pressure), history of seizures or kidney disease
  • You are taking any medications (prescription or nonprescription) or have taken any within the last 14 days.
  • You ever had an allergic reaction to any medication
  • You are pregnant or thinking of becoming pregnant, or if you are breast-feeding.
  • There are conditions which can change the speed at which the body would normally eliminate the drug over time and you should tell your doctor, as APO-MEMANTINE dosage may have to be adjusted if:

    • You have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet)
    • You are suffering from renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction [kidney problems])
    • You have a urinary tract infection

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with APO-MEMANTINE include:

  • NMDA-receptor antagonists

    (e.g.amantadine)

  • Cimetidine
  • Ranitidine
  • Procainamide
  • Quinidine
  • Quinine
  • Hydrochlorothiazide (or any combination

    with hydrochlorothiazide)

  • Anticholinergics (generally used to treat

    movement disorders or intestinal cramps)

  • L-dopa and dopaminergic agonists (drugs

    such as bromocriptine, ropinirole, pramipexole)

  • Ketamine
  • Dextromethorphan (found in cough syrup

    labeled DM)

  • Anticoagulant (blood thinner) medications

    taken by mouth

PROPER USE OF THIS MEDICATION

Usual dose:

  • It is important that you take APO-

    MEMANTINE exactly as your doctor has instructed.

  • Usually your doctor will prescribe 20 mg per

    day, which you will take as two separate doses of 10 mg. In order to reduce the risk of side effects this dose will be achieved gradually by the following daily treatment scheme, starting at a dose of 5 mg per day:

10 mg Tablets
AMPM
Week 1½ tabletNone
Week 2½ tablet½ tablet
Week 31 tablet½ tablet
Week 4 and beyond1 tablet1 tablet
  • Never change the dose of APO-

    MEMANTINE unless your doctor tells you to.

  • Swallow the tablets whole with some water.

    Do not chew tablets. APO-MEMANTINE can be taken with or without food.

  • Continue to take APO-MEMANTINE as

    long as directed by your doctor and you do not experience any unacceptable side effects. Your doctor should assess your treatment on a regular basis.

Overdose:

If you think you have taken too much APO-MEMANTINE, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

  • If you miss a dose, do not worry. Do not take the missed tablet(s) - just take the next dose when it is due.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, APO-MEMANTINE can cause side effects, although not everybody gets them. In general, these are mild to moderate. If any of the side effects become severe or if they are troublesome or persistent, talk to your doctor.

Common side effects (affects 1 to 10 users in 100) may include:

  • headache
  • sleepiness
  • constipation
  • tiredness
  • confusion
  • hallucinations (strange visions or sounds)
  • vomiting
  • loss of appetite
  • dizziness
  • sleep disturbance
  • anxiety
  • high blood pressure
  • change in frequency of urination Uncommon side effects (affects 1 to 10 users in 1000) may include:

    • fungal infections
    • changes in vision
    • skin allergies

Your doctor will tell you whether your illness allows you to drive or operate machinery. Also, as this product may cause sleepiness or dizziness, do not

drive or operate machinery under these conditions.

Alzheimer’s disease has been associated with depression, thoughts of suicide and suicide. These events have been reported in patients treated with APO-MEMANTINE.

If you have previously experienced epileptic seizures, there is a possibility that APO-MEMANTINE may increase the chances of one occurring.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency treatment

Only if

severe

In all cases
UncommonFungal infection

Abnormal gait

[Abnormal way of

walking]

Heart failure [persistent chest pain, rapid heart rate, severe shortness of breath,

swelling of legs or

ankles,

increased tiredness, lack of

appetite,

confusion]

Venous blood clotting [pain, swelling,

changes in skin color, increased

warmth in

one leg]

Very rareSeizures [loss of
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and seek immediate emergency treatment
Only if severeIn all cases
consciousness with uncontrollable shaking]

Hepatitis/hepa tic failure

[yellow skin and eyes, nausea, loss of appetite, dark coloured urine]

Inflammation of the pancreas

[severe upper stomach pain, often with nausea and vomiting]

psychotic reactions

Serious skin reactions

[rash, red skin, blistering of the lips, eyes or mouth, skin peeling]

Very rare (continued)

For example: Stevens-

Johnson

Syndrome: Severe rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacist

Stop

taking

drug and seek

immediate emergency treatment

Only if

severe

In all cases

Acute

Generalized Exanthemato us Pustulosis: Red rash

covered with small pus-

filled bumps that can

spread over the body,

sometimes with a fever Erythema

Multiforme: Rash that

may blister, with spots that look like small targets

This is not a complete list of side effects. For any unexpected effects while taking APO-MEMANTINE, contact your doctor or pharmacist.

If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

HOW TO STORE IT

  • As with all medicines, keep APO-MEMANTINE

    out of the reach of children.

  • Store your tablets at room temperature between

    15°C-30°C.

  • If your doctor tells you to stop taking your

    medicine you should return any leftover tablets to the pharmacist unless the doctor tells you to keep them at home.

REMEMBER: This medicine is for YOU or for someone in your care. Only a doctor can prescribe it, so never offer it to any other person, even if their symptoms seem to be the same as yours or as

for the person in your care.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse

    Reaction Reporting (http://www.hc-sc.gc.ca/dhpmps/medeff/report-declaration/index-eng.php) for information on how to report online, by mail or by fax; or

  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about APO-MEMANTINE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this patient medication information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website

    http://www.apotex.ca/products, or by calling 1-800-667-4708.

Last revised: October 23, 2018

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02366487

Revision date stated in the text: October 23, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Memantine

Rx or OTC
Prescription (Rx)?
DIN 02366487
Schedule(s) PRESCRIPTION
Active ingredient(s) Memantine hydrochloride 10 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06D Anti-dementia drugs
        1. N06DX Other anti-dementia drugs
          1. N06DX01 Memantine
Company APOTEX INC
Current status Marketed
Current status date May 25, 2020

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.